1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CSPC Pharmaceutical Group Ltd.
  6. News
  7. Summary
    1093   HK1093012172

CSPC PHARMACEUTICAL GROUP LTD.

(1093)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-06-28 am EDT
7.900 HKD   +1.41%
06/22CSPC Pharmaceutical Gets Biologic License Approval from China for Bone Treatment
MT
06/22CSPC Pharmaceutical Group Limited Announce Biologic License Application for Jmt103 Accepted by the NMPA
CI
06/14China Grants Approval, Generic Drug Status to CSPC Pharma's Dopamine Agonist
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CSPC Pharmaceutical Group Limited Announces Appointment of Wu Guizhen as Independent Non-Executive Director

05/27/2022 | 06:49am EDT

The Board of Directors of CSPC Pharmaceutical Group Limited announced that Ms. Wu Guizhen has been appointed as an independent non-executive director of the Company with effect from 27 May 2022. Ms. Wu, aged 62, is the Chief Expert of Biosafety of the Chinese Center for Disease Control and Prevention.


© S&P Capital IQ 2022
All news about CSPC PHARMACEUTICAL GROUP LTD.
06/22CSPC Pharmaceutical Gets Biologic License Approval from China for Bone Treatment
MT
06/22CSPC Pharmaceutical Group Limited Announce Biologic License Application for Jmt103 Acce..
CI
06/14China Grants Approval, Generic Drug Status to CSPC Pharma's Dopamine Agonist
MT
06/10Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$11.2 From 11.64, Keeps at..
MT
06/02Hong Kong Hang Seng Down 1% On Wall Street Cues, Central Bank Outlooks
MT
05/31Hong Kong Hang Seng Up 1.2% on Easing China Restrictions, Stimulus Outlook
MT
05/31CSPC Pharmaceutical's Hepatitis B Medication Gets Chinese Government Approval
MT
05/31CSPC PHARMACEUTICAL GROUP LTD. : Ex-dividend day for final dividend
FA
05/27CSPC Pharmaceutical Group Limited Announces Change of CEO
CI
05/27CSPC Pharmaceutical Group Limited Announces Appointment of Wu Guizhen as Independent No..
CI
More news
Analyst Recommendations on CSPC PHARMACEUTICAL GROUP LTD.
More recommendations
Financials
Sales 2022 36 633 M 4 669 M 4 669 M
Net income 2022 7 161 M 913 M 913 M
Net cash 2022 14 397 M 1 835 M 1 835 M
P/E ratio 2022 12,9x
Yield 2022 1,98%
Capitalization 94 133 M 11 999 M 11 999 M
EV / Sales 2022 2,18x
EV / Sales 2023 1,81x
Nbr of Employees 24 746
Free-Float 70,4%
Chart CSPC PHARMACEUTICAL GROUP LTD.
Duration : Period :
CSPC Pharmaceutical Group Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSPC PHARMACEUTICAL GROUP LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 7,79 HKD
Average target price 12,01 HKD
Spread / Average Target 54,2%
EPS Revisions
Managers and Directors
Cui Long Zhang Vice Chairman & Chief Executive Officer
Dong Chen Cai Chairman
Bo Wang Independent Non-Executive Director
Chuan Chen Independent Non-Executive Director
Chun Kwok Au Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
CSPC PHARMACEUTICAL GROUP LTD.-8.03%11 856
JOHNSON & JOHNSON6.56%479 678
ELI LILLY AND COMPANY17.88%293 110
PFIZER, INC.-12.63%289 466
ROCHE HOLDING AG-15.91%272 090
ABBVIE INC.12.51%269 202